MedTrace Logo

Clinical Experiment of Helicobacter Pylori Transmission

NCT00550368 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2016-12-06

Study results available
· View outcomes & findings →

Summary

The study proposes to test whether chronic infection with Helicobacter pylori protects individuals from symptomatic infection with enteropathogenic E. coli. The study will also evaluate the effect of gastric acidity in this relationship.

Conditions

Interventions

BIOLOGICAL

Biological intervention: Enteropathogenic E. coli

5x10\^8 or 1x10\^9 organisms of EPEC were administered to all participants.

Sponsors & Collaborators

Principal Investigators

  • Julie Parsonnet · Stanford University

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00550368 on ClinicalTrials.gov